90
4
5
1
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T41099 | EGFR Protein Tyrosine Kinase Substrate | ||
EGFR Protein Tyrosine Kinase Substrate is a EGFR protein tyrosine kinase substrate. | |||
T9865 | Almonertinib mesylate | EGFR | |
Almonertinib mesylate is an irreversible inhibitor of EGFR tyrosine kinase with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate can be used in the non-small cell lung cancer st... | |||
T4015 | HG-14-10-04 | ALK | |
HG-14-10-04 is a potent and specific ALK inhibitor. | |||
T3024 | Avitinib | AC0010 | EGFR , JAK , BTK |
Avitinib (AC0010), also known as AC0010 or AC0010MA, is an orally available, irreversible, epidermal growth factor receptor (EGFR) mutant-selective inhibitor, with potential antineoplastic activity. Upon oral administrat... | |||
T39275 | Befotertinib | D-0316,Befotertinib | EGFR |
Befotertinib (D-0316) is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer. | |||
T6712 | Tyrphostin AG 879 | AG 879 | Apoptosis , EGFR , Trk receptor , HER , PDGFR |
Tyrphostin AG 879 (AG 879) effectively inhibits HER2/ErbB2 (IC50: 1 μM), 100- and 500-fold higher selective to ErbB2 than EGFR and PDGFR. | |||
T4185 | Lavendustin C | HDBA,NSC 666251 | CaMK , EGFR , Tyrosinase , Src |
lavendustin C (NSC 666251) is a potent inhibitor of epidermal growth factor (EGF) receptor-associated tyrosine kinase. | |||
T9304 | (S)-Sunvozertinib | N-[5-[[4-[5-Chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide,DZD9008 | EGFR , HER |
(S)-Sunvozertinib (DZD9008) is a rationally designed selective, irreversible EGFR/HER2 inhibitor. | |||
T77746 | Tyrosine kinase-IN-7 | EGFR , Antiviral | |
Tyrosine kinase-IN-7 is a potent inhibitor of the tyrosine kinase EGFR, inhibiting EGFR(WT) and EGFR(T790M) and showing anti-cancer and anti-tumor activity in a variety of cancer cell lines. Tyrosine kinase-IN-7 has pote... | |||
T60108 | PDGFR Tyrosine Kinase Inhibitor III | PDGF Receptor Tyrosine Kinase Inhibitor III | PDGFR |
PDGFR Tyrosine Kinase Inhibitor III (PDGF Receptor Tyrosine Kinase Inhibitor III) (PDGF Receptor Tyrosine Kinase Inhibitor III) is a multikinase inhibitor that inhibits PDGFR, EGFR, FGFR, PKA, and PKC, respectively. PDGF... | |||
T4326 | AG 555 | Tyrphostin B46,Tyrphostin AG 555 | EGFR , Reverse Transcriptase |
AG 555 (Tyrphostin B46) is an EGFR tyrosine kinase inhibitor. | |||
T2307 | Icotinib Hydrochloride | BPI-2009H | EGFR |
Icotinib Hydrochloride (BPI-2009H) is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity. Icotinib selectively inhibits the wild-type ... | |||
T2034 | AG1557 | AG-1557,AG 1557 | EGFR , HER |
AG1557 (AG-1557) is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194). | |||
T21322 | Mavelertinib | PF 06747775,PFE-X775,PF-06747775,PF-7775,PF 6747775,PF6747775 | EGFR |
Mavelertinib (PF-06747775) is an orally available, selective and potent EGFR tyrosine kinase (EGFR TKI) inhibitor with inhibitory effects on T790M/L858R and T790M/Del, and can be used in the study of oncology and respira... | |||
T7649 | Tyrphostin A1 | AG9,Tyrphostin 1 | EGFR , Interleukin |
Tyrphostin A1 (Tyrphostin 1) is an inhibitor of EGFR tyrosine kinase . | |||
T14692 | BMX-IN-1 | BMX kinase inhibitor | BTK |
BMX-IN-1 (BMX kinase inhibitor) is a selective inhibitor of bone marrow tyrosine kinase on chromosome X (BMX, IC50 = 8 nM) and the related Bruton’s tyrosine kinase (BTK, IC50 = 10.4 nM), but BMX-IN-1 is more than 47-656 ... | |||
T7175 | Alflutinib mesylate | AST2818 mesylate | EGFR |
Alflutinib mesylate (AST2818 mesylate) ,is an irreversible tyrosine kinase inhibitor that selectively inhibits EGFR mutations, especially T790M. | |||
T4694 | AG-1557 hydrochloride (189290-58-2(free base)) | EGFR , HER | |
AG-1557 hydrochloride is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194). | |||
T73334 | Larotinib | EGFR , IRAK , Tyrosine Kinases , BTK | |
Larotinib is an orally active, potent, and broad-spectrum tyrosine kinase inhibitor (TKI) with an IC50 of 0.6 nM for EGFR. | |||
T19814 | CP-380736 | PF 00520893,CP380736,PF00520893,CP 380736,PF-00520893 | EGFR |
CP-380736 (PF-00520893) is an epidermal growth factor receptor (EGFR) inhibitor. EGFR is a tyrosine kinase that activates MAPK, JNK, and Akt pathways, and is an important mediator of several types of cancer. | |||
T35914 | Epitinib succinate | HMPL-813 succinate | EGFR |
Epitinib succinate (HMPL-813 succinate) is an orally active and brain penetration EGFR tyrosine kinase inhibitor and can be used in studies about cancer. | |||
T3569 | SU5214 | SU 5214 | VEGFR , Tyrosinase |
SU5214 is a modulator of tyrosine kinase signal transduction. | |||
T11158 | EGFR-IN-11 | EGFR | |
EGFR-IN-11 is a selective inhibitor of EGFR-tyrosine kinase and induces cell apoptosis. EGFR-IN-11 inhibits triple mutant EGFRL858R/T790M/C797S with an IC50 of 18 nM and arrests cell cycle at G0/G1. | |||
T2325 | Neratinib | HKI-272 | EGFR , HER |
Neratinib (HKI-272) (HKI-272) is an orally available, irreversible tyrosine kinase inhibitor for HER2 and EGFR (IC50: 59/92 nM), respectively. | |||
T8976 | PD-089828 | EGFR , FGFR , PDGFR , Src | |
PD 089828 is a competitive inhibitor of the receptor tyrosine kinases FGFR1, PDGFRβ, and EGFR (IC50s = 0.15, 1.76, and 5.47 µM, respectively) and a noncompetitive inhibitor of the nonreceptor tyrosine kinase c-Src (IC50 ... | |||
TQ0166 | Tesevatinib | KD-019,XL-647,EXEL-7647 | EGFR , VEGFR , FLT , Ephrin Receptor |
Tesevatinib (XL-647) is an orally available, multi-target tyrosine kinase inhibitor (IC50s: 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR, ErbB2, KDR, Flt4, and EphB4). | |||
T6217 | LFM-A13 | PLK , JAK , BTK | |
LFM-A13(IC50=2.5 μM), a specific Bruton's tyrosine kinase (BTK), is more than 100-fold specificity than other protein kinases, such as JAK1, JAK2, HCK, EGFR, and IRK. | |||
T79888 | EGFR-IN-87 | EGFR | |
EGFR-IN-87 is an EGFR tyrosine kinase inhibitor with potent inhibitory activity, exhibiting IC50 values of 3.1 nM, 1.3 nM, and 7.1 nM against EGFR_d746-750, EGFR_L858R/T790M, and EGFR_WT, respectively, in A431 cells. It ... | |||
T11213 | Epertinib hydrochloride | S-22611 hydrochloride | EGFR , HER |
Epertinib hydrochloride (S-22611 hydrochloride) shows potent antitumor activity. Epertinib hydrochloride is a potent, orally active, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4, with IC50s ... | |||
T21622 | Tyrphostin A25 | AG-82,Tyrphostin AG 82,RG-50875 | EGFR , GPR |
Tyrphostin A25 (Tyrphostin AG 82) is a specific EGFR tyrosine kinase inhibitor and GPR35 agonist with an IC50 value of 0.94 μM for GPR35 and an EC50 value of 5.3 μM for GPR35. | |||
T8327 | ONO-7475 | Trk receptor , TAM Receptor | |
ONO-7475 is an inhibitor with high specificity for anexelekto and MER tyrosine kinase | |||
T6136 | Canertinib | PD-183805,CI-1033 | EGFR |
Canertinib (CI-1033) is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hyp... | |||
T9754 | BLU-945 | BLU945,BLU 945 | EGFR |
BLU-945 is a potent, highly selective, reversible, and orally active epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, effective against EGFR with L858R and/or exon 19 deletion mutations, T790M, and C797... | |||
T10534 | BI-4020 | EGFR | |
TQ0271 | Falnidamol | BIBX 1382 | EGFR |
Falnidamol (BIBX 1382) is an orally active, selective EGFR tyrosine kinase inhibitor with an IC50 of 3 nM. Falnidamol displays > 1000-fold lower potency against ErbB2 (IC50=3.4 μM) and a range of other related tyrosine k... | |||
T1773 | Afatinib Dimaleate | BIBW2992,Afatinib,BIBW 2992MA2,Afatinib (BIBW2992) Dimaleate | EGFR , HER , Autophagy |
Afatinib Dimaleate (BIBW 2992MA2) is an orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, with antineoplastic act... | |||
T10870L | CP-547632 | VEGFR , FGFR , PDGFR , BTK | |
T0078L | Lapatinib ditosylate monohydrate | Lapatinib ditosylate monohydrate,Lapatinib ditoluenesulfonate monohydrate,Lapatinib tosilate hydrate,Lapatinib tosilate,Tykerb,Tyverb | EGFR , Ferroptosis , Autophagy |
Lapatinib ditosylate (Lapatinib tosilate) monohydrate is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib ditosylate monohydrate therapy is associated w... | |||
T2064 | Semaxinib | SU5416 | VEGFR |
Semaxinib (SU5416) is a potent and selective VEGFR2 inhibitor (IC50: 1.23 μM), 20-fold more selective for VEGFR than PDGFRβ, lack of activity against InsR, EGFR, and FGFR. Semaxanib reversibly inhibits ATP binding to the... | |||
T16549 | PKI-166 | VEGFR | |
PKI-166 is an oral inhibitor of EGF-R tyrosine kinase (IC50:0.7 nM) that is both effective and selective. PKI-166 can effectively inhibit the growth and metastasis of various human cancer cells including pancreatic cance... | |||
T22827 | GW 583340 dihydrochloride | Others | |
dual EGFR/ErbB2 tyrosine kinase inhibitor | |||
T34916 | Transtinib | ||
Transtinib is an effective and irreversible EGFR tyrosine kinase inhibitor (EGFR-TKI) that is active against L858R/T790M mutated NSCLC cell lines and xenografts. | |||
T71902 | CHEMBL94431 | ||
CHEMBL94431 is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. | |||
T36643 | PKI-166 hydrochloride | ||
Potent EGFR-kinase inhibitor (IC50 = 0.7 nM). Displays >3000-fold selectivity against a panel of serine/threonine kinases. Reduces metastasis and angiogenesis in a mouse model of pancreatic cancer. Antihypertensive and o... | |||
T61441 | NSC381467 | ||
NSC381467, a potent and orally active inhibitor of the EGFR tyrosine kinase (EGFR-TK), exhibits robust antiproliferative activity, making it a promising candidate for cancer research [1]. | |||
T70317 | BIBU-1361 dihydrochloride | ||
BIBU-1361 dihydrochloride is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase that blocks downstream EGFR signaling events such as MAPKK/MAPK activation. | |||
T11385 | Gefitinib N-oxide | Others | |
Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells. Gefitinib N-oxide is the N-oxide derivative of Gefitinib. | |||
T11213L | Epertinib | S-22611 | EGFR , HER |
Epertinib is a reversible and selective tyrosine kinase inhibitor of EGFR, HER2, and HER4 (IC50s: 1.48 nM, 7.15 nM, and 2.49 nM). It displays a strong antitumor activity. | |||
T70227 | BPIQ-I | PD 159121 | |
BPIQ-I (PD 159121), an ATP-competitive EGFR tyrosine kinase inhibitor, exhibits potent anti-proliferative activity. | |||
T11229 | Erlotinib-d6 | OSI-774 D6,NSC 718781 D6,CP-358774 D6 | Others |
Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR. Erlotinib D6 is a deuterium labeled Erlotinib . |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T1181 | Gefitinib | ZD1839 | EGFR , Tyrosine Kinases , Autophagy |
Gefitinib (ZD1839) is an EGFR first-generation inhibitor with oral activity that inhibits the EGFR 19 Del and L858R mutations. Gefitinib has antitumor activity and is used for the treatment of EGFR-mutated non-small-cell... | |||
T4183 | Lavendustin A | RG-14355,NSC 678027 | EGFR , Tyrosinase |
lavendustin A (RG-14355) is a potent, cell-permeable inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase. | |||
T6427 | Butein | 2’,3,4,4’-tetrahydroxy Chalcone | Apoptosis , EGFR , Others , PDE , Autophagy |
Butein (2’,3,4,4’-tetrahydroxy Chalcone), a plant polyphenol, is isolated from Rhus verniciflua. It can inhibit the activation of protein tyrosine kinase, NF-κB and STAT3, and also can inhibit EGFR. | |||
TN2504 | 1,5-Dihydroxyxanthone | EGFR , AChR | |
1,5-Dihydroxyxanthone exhibits the epidermal growth factor receptor (EGFR) -tyrosine kinase inhibitory activity, with the IC50 value of 90.34 nM. It may have anticholinesterase activity on acetylcholinesterase (AChE) and... |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPJ-00648 | EGFR vIII Protein, Human, Recombinant (His) | Human | HEK293 Cells |
EGFR vIII Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 61-75 Kda and the accession number is NP_001333870. | |||
TMPJ-00647 | EGFR vIII Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
EGFR vIII Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with C-Fc tag. The predicted molecular weight is 90-120 KDa and the accession number is NP_001333870. | |||
TMPJ-00646 | EGFR vIII Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
EGFR vIII Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-6xHis-Avi tag. The predicted molecular weight is 60-90 KDa and the accession number is NP_001333870. | |||
TMPY-04484 | ACK1 Protein, Human, Recombinant (GST) | Human | Baculovirus Insect Cells |
ACK1 (also known as ACK, TNK2, or activated Cdc42 kinase) is a structurally unique non-receptor tyrosine kinase that is expressed in diverse cell types. This downstream effector of CDC42 mediates CDC42-dependent cell mig... | |||
TMPK-00870 | AREG Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 Cells |
Amphiregulin (AREG) is a ligand of the epidermal growth factor receptor (EGFR), a widely expressed transmembrane tyrosine kinase. AREG is synthesized as a membrane-anchored precursor protein that can engage in juxtacrine... |
カタログ番号 | 製品名 | ||
---|---|---|---|
L9410 | Covalent Inhibitor Library | 1920 compounds | |
A unique collection of 1920 covalent Inhibitors and other molecules with common warheads like chloroacetyl,2-Chloropropionyl,Acryloyl,sulfonyl fluoride, alkyne,acrylamide, ketocarbonyl,disulfide bond, etc. |